Pharming Group N.V.
PHAR
$13.40
-$0.879-6.16%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 4.69M | 2.86M | -1.22M | -12.45M | |
| Total Depreciation and Amortization | 2.70M | 1.82M | -293.00K | 5.92M | |
| Total Amortization of Deferred Charges | -- | 852.00K | -- | -- | |
| Total Other Non-Cash Items | 5.74M | 10.89M | -2.43M | -72.00K | |
| Change in Net Operating Assets | -1.39M | -7.09M | -9.29M | -1.05M | |
| Cash from Operations | 11.74M | 9.33M | -13.22M | -7.65M | |
| Capital Expenditure | -128.00K | -130.00K | -214.00K | -80.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 17.08M | -9.66M | 36.61M | 744.00K | |
| Cash from Investing | 16.96M | -9.79M | 36.39M | 664.00K | |
| Total Debt Issued | -- | 0.00 | 104.80M | -- | |
| Total Debt Repaid | -1.07M | -1.52M | -135.11M | -1.03M | |
| Issuance of Common Stock | 1.05M | 2.09M | 2.58M | 884.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2.74M | -2.78M | -573.00K | -2.32M | |
| Cash from Financing | -2.76M | -2.20M | -28.30M | -2.47M | |
| Foreign Exchange rate Adjustments | 6.06M | -3.06M | 381.00K | -395.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 32.00M | -5.72M | -4.75M | -9.85M | |